Current role
Biotechnology · Healthcare
CEO, Board Member
2023-02-23–present
Sam Kintz, M.B.A.
Board Member
Enliven Therapeutics, Inc. (ELVN)Equibles does not estimate personal net worth.
Get an email with a short summary when Enliven Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ELVN alertsAbout Sam Kintz, M.B.A.
Sam Kintz, M.B.A. is recorded as CEO and Board Member at Enliven Therapeutics, Inc. (ELVN) since February 23, 2023. Enliven Therapeutics, Inc. reported in an 8-K filed March 1, 2023 that Sam Kintz, M.B.A. was appointed Board, effective February 23, 2023. Enliven Therapeutics, Inc. reported in an 8-K filed March 1, 2023 that Sam Kintz, M.B.A. was appointed President and Chief Executive Officer, effective February 23, 2023. Enliven Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Enliven Therapeutics, Inc. includes Richard Fair (CEO and Board Member), Rick Fair (CEO and Board Member), Samuel Kintz (CEO) and 7 others.
“Sam Kintz, M.B.A., age 37, is one of Former Enliven’s co-founders and has served as its President and Chief Executive Officer and a member of its board of directors since June 2019, and was appointed as the President, Chief Executive Officer, and a member of the Board of directors of the Company in connection with the closing of the Merger.”
“Pursuant to the Merger Agreement, on February 23, 2023, the Board appointed Sam Kintz, M.B.A, as President and Chief Executive Officer of the Company and Benjamin Hohl as Chief Financial Officer of the Company.”
Affiliation history
-
Current
2023-02-23–present
-
Current
2023-02-23–present
Company network
Leadership on record at Enliven Therapeutics, Inc.
- Richard Fair CEO, Board Member
- Rick Fair CEO, Board Member
- Samuel Kintz CEO
- Richard Heyman, Ph.D. Chairman, Board Member
- Ben Hohl CFO
- Benjamin Hohl CFO
- Anish Patel COO
- Andrew Phillips, Ph.D. Board Member
- Continuing Directors Board Member
- Jake Bauer Board Member